Genitourinary Cancers | Topics

Long-Term Follow-up of Mohs Surgery Shows Promise for Localized Penile Cancer
December 04, 2020

The procedure provided effective, long-term local control for patients with localized penile cancer, highlighting the need for a multidisciplinary approach to patient care.

FDA Approves Pembrolizumab for BCG-Unresponsive NMIBC
February 13, 2020

The FDA  approved pembrolizumab (Keytruda) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors who are ineligible for or chose to not undergo cystectomy.

Study Shows Efficacy of Single-Cycle BEP in Preventing Testicular Cancer Recurrence
January 08, 2020

Results of this phase III trial could change the current standard of care for treating nonseminomatous or combined germ cell tumors of the testis.